Enhanced Immunogenicity and Protective Efficacy of a <italic toggle="yes">Campylobacter jejuni</italic> Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21

Enhanced Immunogenicity and Protective Efficacy of a <italic toggle="yes">Campylobacter jejuni</italic> Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21

ABSTRACT Campylobacter jejuni is among the most common causes of diarrheal disease worldwide and efforts to develop protective measures against the pathogen are ongoing. One of the few defined virulence factors targeted for vaccine development is the capsule polysaccharide (CPS). We have developed a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amritha Ramakrishnan, Nina M. Schumack, Christina L. Gariepy, Heather Eggleston, Gladys Nunez, Nereyda Espinoza, Monica Nieto, Rosa Castillo, Jesus Rojas, Andrea J. McCoy, Zoltan Beck, Gary R. Matyas, Carl R. Alving, Patricia Guerry, Frédéric Poly, Renee M. Laird
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2019
Materias:
campylobacter
Campylobacter jejuni
adjuvants
conjugate
liposomes
vaccines
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/e799a4b22d0c4f43842f64674b689c7b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/e799a4b22d0c4f43842f64674b689c7b

Ejemplares similares